Sakura Hiraide

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

C. Ishioka, Masanobu Takahashi, Sakura Hiraide, 2021, International Journal of Clinical Oncology.

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study

C. Ishioka, Masanobu Takahashi, H. Shirota, 2022, Cancer management and research.

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

C. Ishioka, Masahiro Takahashi, Masanobu Takahashi, 2018, Cancer management and research.

Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis.

C. Ishioka, Masanobu Takahashi, H. Shirota, 2018, The Tohoku journal of experimental medicine.

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)

Sakura Hiraide, S. Ono, S. Kato, 2017, Case Reports in Oncology.

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma

C. Ishioka, Mika Watanabe, Masanobu Takahashi, 2021, Oncology letters.

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

C. Ishioka, Masanobu Takahashi, H. Shirota, 2019, International Journal of Clinical Oncology.

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer

C. Ishioka, Masanobu Takahashi, Sakura Hiraide, 2021, Cancer science.